EMERYVILLE, Calif., Jan. 20, 2021 /PRNewswire/ — Dynavax Technologies Company (Nasdaq: DVAX), a biopharmaceutical organization concentrated on acquiring and commercializing vaccines, today introduced that Kelly MacDonald has been appointed Senior Vice President and Chief Economic Officer. Ms. MacDonald will be part of the organization helpful March 1, 2021.
As previously introduced, immediately after 14 yrs at Dynavax, Main Monetary Officer Michael Ostrach is retiring. Mr. Ostrach has agreed to continue to be readily available as an advisor to the Company thereafter.
“Michael’s contributions and unwavering commitment to Dynavax have been important to the achievements of our corporation. We are exceptionally fortuitous to have had his guidance about the many years and now as a strategic advisor to make sure a seamless changeover to his successor,” commented Ryan Spencer, Main Govt Officer of Dynavax. “Kelly is an accomplished economic leader with a deep knowing of company and business finance and will be an asset as we mature our business enterprise of developing vaccines to aid avert the unfold of infectious health conditions. On behalf of the board and the other customers of the government crew, it is a satisfaction to welcome Kelly to Dynavax.”
“This is an enjoyable time to join Dynavax as it proceeds to create a primary vaccine enterprise, addressing urgent world-wide wellness requirements,” commented Kelly MacDonald. “I share the very long-time period determination to Dynavax’ eyesight of collaboration, innovation and progress and seem ahead to primary the finance and accounting team in executing the firm’s strategic and economic objectives.”
Ms. MacDonald joins Dynavax from Ironwood Pharmaceuticals where by she held roles of increasing duty. In her last part at Ironwood Ms. MacDonald served as Main Accounting Officer and Vice President, Finance where by she led the Company’s company accounting and finance procedures, business possibility management, treasury and money allocation system. While at Ironwood, she also held various other managerial roles, supplying finance and accounting help for the company’s strategic organizing, R&D portfolio management, international business enhancement, solution launches and commercial execution. Prior to signing up for Ironwood, Kelly was a Supervisor in the Health Industries Assurance Apply at PricewaterhouseCoopers, mostly serving purchasers in life sciences and technological know-how sectors.
Ms. MacDonald is a Certified Community Accountant (CPA) and retains a Learn of Business Administration from the Isenberg Faculty of Management at the University of Massachusetts and a Bachelor of Science in Accounting from Fairfield College.
Dynavax is a commercial stage biopharmaceutical company establishing and commercializing novel vaccines. The Company’s to start with business item, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], is authorised in the U.S. for prevention of an infection induced by all recognized subtypes of hepatitis B virus in older people age 18 years and older. Dynavax is also advancing CpG 1018 as a leading vaccine adjuvant as a result of analysis collaborations and partnerships. Present collaborations are centered on adjuvanted vaccines for COVID-19, pertussis and common influenza. For far more information and facts, stop by www.dynavax.com and adhere to the company on LinkedIn.
Nicole Arndt, Senior Manager, Investor Relations
Derek Cole, President
Investor Relations Advisory Solutions
Perspective authentic content material to down load multimedia:http://www.prnewswire.com/information-releases/dynavax-appoints-kelly-macdonald-as-main-monetary-officer-301211428.html
Source Dynavax Technologies